HomeRVNC • NASDAQ
add
Revance Therapeutics Inc
Previous close
$5.18
Day range
$5.10 - $5.43
Year range
$2.30 - $9.74
Market cap
551.11M USD
Avg Volume
3.52M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 65.39M | 20.17% |
Operating expense | 82.27M | -11.68% |
Net income | -37.47M | 44.33% |
Net profit margin | -57.31 | 53.68% |
Earnings per share | -0.36 | 55.00% |
EBITDA | -33.09M | 37.35% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 232.24M | -27.36% |
Total assets | 494.80M | -17.19% |
Total liabilities | 624.54M | 9.42% |
Total equity | -129.74M | — |
Shares outstanding | 104.82M | — |
Price to book | -4.18 | — |
Return on assets | -17.21% | — |
Return on capital | -23.35% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -37.47M | 44.33% |
Cash from operations | -41.13M | 22.96% |
Cash from investing | -6.89M | 82.57% |
Cash from financing | -3.41M | -103.50% |
Net change in cash | -51.43M | -1,228.62% |
Free cash flow | -37.67M | -26.57% |
About
Founded
1999
Headquarters
Website
Employees
597